Virtual Reality for Freezing of Gait in Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to address freezing of gait, a troubling symptom in Parkinson's disease where patients suddenly can't start or continue walking. Researchers will study brain activity during walking episodes using virtual reality tasks, including Dual Task, External Cueing, and VR Freezing Task, to learn more about this issue. Participants should have Parkinson's disease with a specific deep brain stimulation device and be able to walk indoors without assistance. Half of the participants will regularly experience freezing of gait, while the other half will not. The goal is to develop better treatment strategies for this challenging symptom. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to improved treatments for Parkinson's disease.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these interventions are safe for addressing freezing of gait in Parkinson's disease?
Research shows that the treatments under study—Dual Task, External Cueing, and VR Freezing Task—are generally safe for people with Parkinson's disease.
For Dual Task treatments, previous studies indicate that people with Parkinson's can manage them well, even though multitasking might be challenging. These studies aim to improve walking, suggesting it's a practical approach.
External Cueing uses signals to guide walking and has shown promising results in improving walking patterns. Research highlights that patients usually don't experience increased brain activity, indicating the cues work effectively without causing extra stress.
Virtual Reality (VR) tasks study and understand freezing of gait in Parkinson's. They provide a safe way to explore and train walking behavior. Studies show that VR can help improve balance and walking, indicating it's a well-tolerated method.
Overall, these treatments focus on improving walking and appear safe based on current research.12345Why are researchers excited about this trial?
Researchers are excited about using virtual reality (VR) for treating freezing of gait in Parkinson's disease because it offers a novel, immersive way to address this challenging symptom. Unlike traditional treatments like medication and physical therapy, which often have limited success in managing freezing episodes, VR provides a unique platform for dual-task training and external cueing, which are believed to improve motor control and brain plasticity. This innovative approach could lead to more effective and engaging interventions, potentially improving mobility and quality of life for Parkinson's patients.
What evidence suggests that this trial's treatments could be effective for freezing of gait in Parkinson's disease?
Research has shown that virtual reality (VR) and cueing strategies might help manage walking difficulties in people with Parkinson's disease. In this trial, participants will engage in various interventions, including the VR Freezing Task, Dual Task, and External Cueing. Studies have found that augmented reality (AR) cues can improve walking, although they might not directly reduce freezing episodes. One study discovered that VR can affect walking patterns, especially when using detailed VR environments and large spaces. Another study suggested that performing two tasks simultaneously, along with touch-based cues, might improve walking speed and step length. These findings indicate that VR and cueing strategies could benefit managing walking issues in Parkinson's, but more research is needed to confirm their effectiveness.678910
Are You a Good Fit for This Trial?
This trial is for individuals with Parkinson's Disease who experience freezing of gait, which is when they can't start or continue walking. Participants should be able to walk and have a deep brain stimulation (DBS) device implanted.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline neurophysiology and kinematics measurements are taken during initial gait interventions
Experimental Intervention
Participants undergo gait interventions with neurophysiology and kinematics measurements in a virtual reality environment
Follow-up
Participants are monitored for safety and effectiveness after interventions
What Are the Treatments Tested in This Trial?
Interventions
- Dual Task
- External Cueing
- VR Freezing Task
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator